Janux Therapeutics, Inc. (JANX) vs Lumexa Imaging Holdings, Inc. Common Stock (LMRI)

A side-by-side comparison of Janux Therapeutics, Inc. and Lumexa Imaging Holdings, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Janux Therapeutics, Inc. logo
JANX
Janux Therapeutics, Inc.
$1.02B
$16.80HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Lumexa Imaging Holdings, Inc. Common Stock logo
LMRI
Lumexa Imaging Holdings, Inc. Common Stock
$1.02B
$10.59HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT

Total return — JANX vs LMRI

growth of $100 · dividends reinvested · last 1y
JANX +6.2% (+6.2%/yr)LMRI -41.8% (-41.8%/yr)JANX compounded faster over this window
406080100120Start $1002026$106$58
JANX LMRI

JANX vs LMRI: by the numbers

  • •JANX is the larger company ($1.02B vs $1.02B market cap).
  • •Both run net losses; LMRI's is the smaller (-2.66% vs -321.81% net margin).

Metrics side by side

Valuation

MetricJANXLMRI
Forward P/EN/A16.49
P/S ratio32.140.97
P/B ratio1.101.65
EV / EBITDAN/A27.89
FCF yieldN/A3.13%

Profitability

MetricJANXLMRI
Gross margin79.71%11.80%
Operating margin-1576.67%1.38%
Net margin-321.81%-2.66%
ROE-11.06%-4.51%
ROIC-15.15%0.86%

Growth (annualized)

MetricJANXLMRI
Revenue CAGR (5Y)105.89%N/A
Total return CAGR (5Y)-6.45%N/A

Go deeper

Full JANX analysisFull LMRI analysisInteractive comparison tool

Dig into the metrics

Janux Therapeutics ROELumexa Imaging Holdings, Inc. Common Stock ROEJanux Therapeutics operating marginLumexa Imaging Holdings, Inc. Common Stock operating marginJanux Therapeutics revenue growthLumexa Imaging Holdings, Inc. Common Stock revenue growthJanux Therapeutics free cash flowLumexa Imaging Holdings, Inc. Common Stock free cash flow

Janux Therapeutics & Lumexa Imaging Holdings, Inc. Common Stock appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.